These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30010779)

  • 1. Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer.
    Hanna GJ; Supplee JG; Kuang Y; Mahmood U; Lau CJ; Haddad RI; Jänne PA; Paweletz CP
    Ann Oncol; 2018 Sep; 29(9):1980-1986. PubMed ID: 30010779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.
    Hanna GJ; Lau CJ; Mahmood U; Supplee JG; Mogili AR; Haddad RI; Jänne PA; Paweletz CP
    Oral Oncol; 2019 Aug; 95():120-126. PubMed ID: 31345379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR.
    Rosing F; Meier M; Schroeder L; Laban S; Hoffmann T; Kaufmann A; Siefer O; Wuerdemann N; Klußmann JP; Rieckmann T; Alt Y; Faden DL; Waterboer T; Höfler D
    Microbiol Spectr; 2024 Jul; 12(7):e0002424. PubMed ID: 38829114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.
    Rosenberg AJ; Izumchenko E; Pearson A; Gooi Z; Blair E; Karrison T; Juloori A; Ginat D; Cipriani N; Lingen M; Sloane H; Edelstein DL; Keyser K; Fredebohm J; Holtrup F; Jones FS; Haraf D; Agrawal N; Vokes EE
    BMC Cancer; 2022 Jan; 22(1):17. PubMed ID: 34980038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal measurement of HPV copy number in cell-free DNA is associated with patient outcomes in HPV-positive oropharyngeal cancer.
    Warlow SJ; Adamowicz M; Thomson JP; Wescott RA; Robert C; Carey LM; Thain H; Cuschieri K; Li LQ; Conn B; Hay A; Nixon IJ; Aitman TJ
    Eur J Surg Oncol; 2022 Jun; 48(6):1224-1234. PubMed ID: 35431082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
    Dahlstrom KR; Li G; Hussey CS; Vo JT; Wei Q; Zhao C; Sturgis EM
    Cancer; 2015 Oct; 121(19):3455-64. PubMed ID: 26094818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.
    Hanna GJ; Roof SA; Jabalee J; Rettig EM; Ferrandino R; Chen S; Posner MR; Misiukiewicz KJ; Genden EM; Chai RL; Sims J; Thrash E; Stern SJ; Kalman NS; Yarlagadda S; Raben A; Clements L; Mendelsohn A; Kaczmar JM; Pandey Y; Bhayani M; Gupta P; Kuperwasser C; Del Vecchio Fitz C; Berger BM
    Clin Cancer Res; 2023 Oct; 29(20):4306-4313. PubMed ID: 37566241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV status predicts for improved survival following chemotherapy in metastatic squamous cell carcinoma of the oropharynx.
    Pike LRG; Hwang WL; Royce TJ; Sanford NN; Mahal BA
    Oral Oncol; 2018 Nov; 86():69-74. PubMed ID: 30409322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer.
    Mattox AK; D'Souza G; Khan Z; Allen H; Henson S; Seiwert TY; Koch W; Pardoll DM; Fakhry C
    Oral Oncol; 2022 May; 128():105805. PubMed ID: 35334415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer.
    Sivars L; Jylhä C; Crona Guterstam Y; Zupancic M; Lindqvist B; Nordenskjöld M; Tham E; Hellman K
    Clin Cancer Res; 2024 Jul; 30(13):2764-2771. PubMed ID: 38669077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer.
    Hanna GJ; Jabalee J; Lukens JN; Sun L; Rettig EM; Ferrandino R; Posner MR; Misiukiewicz KJ; Routman DM; Van Abel KM; Del Vecchio Fitz C; Roof SA
    Oral Oncol; 2024 Nov; 158():107002. PubMed ID: 39159525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus DNA in pharyngeal scrapes as a marker of HPV-related squamous cell cancer of the oropharynx.
    Snietura M; Rutkowski T; Piglowski W; Hajduk A; Wygoda A; Skladowski K; Lange D
    J Clin Virol; 2015 Oct; 71():34-9. PubMed ID: 26370312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in the rate of HPV positive oropharyngeal cancers during 1996-2011 in a case study in Turkey.
    Tural D; Elicin O; Batur S; Arslan D; Oz B; Serdengecti S; Uzel O
    Asian Pac J Cancer Prev; 2013; 14(10):6065-8. PubMed ID: 24289626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk HPV and survival in patients with oral and oropharyngeal squamous cell carcinoma - 5-year follow up of a population-based study.
    Annertz K; Rosenquist K; Andersson G; Jacobsson H; Hansson BG; Wennerberg J
    Acta Otolaryngol; 2014 Aug; 134(8):843-51. PubMed ID: 24930912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
    Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.